Insider · CIK 0001083212

HELLER ALAN L

Reports to the SEC for 7 companies · VERNON HILLS, IL

sec.gov

Transactions

Companies

Filings

CIK

0001083212

Forms 4 and 5

Insider transactions

49 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-03-19	Neos Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−46.9K sh	—	—	0
2021-03-19	Neos Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−18.3K sh	—	—	0
2021-03-19	Neos Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−22.8K sh	—	—	0
2021-03-19	Neos Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.5K sh	—	—	0
2021-03-19	Neos Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−447K sh	—	—	0
2021-03-19	Neos Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−14.8K sh	—	—	0
2020-06-10	Neos Therapeutics, Inc.A Award	Director	AAward	+23.5K sh	—	—	446,819
2019-06-13	Neos Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+46.9K sh	—	—	46,907
2018-11-08	Neos Therapeutics, Inc.P Purchase	Director	PPurchase	+43.5K sh	$2.30	+$100K	423,366
2018-07-02	Neos Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+22.8K sh	—	—	22,756
2017-07-03	Neos Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+18.3K sh	—	—	18,322
2016-07-01	Neos Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+14.8K sh	—	—	14,777
2016-05-19	Neos Therapeutics, Inc.P Purchase	Director	PPurchase	+10K sh	$7.61	+$76.1K	379,888
2015-07-28	Neos Therapeutics, Inc.C Conversion	Director	CConversion	+92K sh	—	—	369,888
2015-07-28	Neos Therapeutics, Inc.C Conversion	Director	CConversion	+20.8K sh	—	—	177,932
2015-07-28	Neos Therapeutics, Inc.C Conversion	Director	CConversion	+100K sh	—	—	277,932
2015-07-28	Neos Therapeutics, Inc.Series C Preferred StockC Conversion	Director	CConversion	−221K sh	—	—	0
2015-07-28	Neos Therapeutics, Inc.Series B-1 Preferred StockC Conversion	Director	CConversion	−240K sh	—	—	0
2015-07-28	Neos Therapeutics, Inc.Series B Preferred StockC Conversion	Director	CConversion	−50K sh	—	—	0
2015-07-27	Neos Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+28.9K sh	$2.31	+$66.8K	155,456
2015-07-27	Neos Therapeutics, Inc.X Exercise of In-Money	Director	XExercise of In-Money	+16.4K sh	$0.02	+$393.792	126,559
2015-07-27	Neos Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,643 sh	$0.32	+$525.76	157,099
2015-07-27	Neos Therapeutics, Inc.Common Stock Warrant (Right to Buy)X Exercise of In-Money	Director	XExercise of In-Money	−16.4K sh	—	—	0
2015-07-27	Neos Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−28.9K sh	—	—	0
2015-07-27	Neos Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,643 sh	—	—	0
2015-07-22	Neos Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	41,397
2011-09-15	SAVIENT PHARMACEUTICALS INCP Purchase	Director	PPurchase	+7,500 sh	$3.99	+$29.9K	40,179
2011-05-26	SAVIENT PHARMACEUTICALS INCA Award	Director	AAward	+5,291 sh	$7.78	+$41.2K	32,679
2011-05-26	SAVIENT PHARMACEUTICALS INCOption to Purchase Common Stock, $0.01 par valueA Award	Director	AAward	−7,031 sh	$7.78	−$54.7K	7,031
2010-06-08	SAVIENT PHARMACEUTICALS INCOption to Purchase Common Stock, $0.01 par valueA Award	Director	AAward	−4,831 sh	$11.38	−$55K	4,831
2010-06-08	SAVIENT PHARMACEUTICALS INCA Award	Director	AAward	+3,514 sh	$11.38	+$40K	27,388
2010-06-08	SAVIENT PHARMACEUTICALS INCA Award	Director	AAward	+3,514 sh	—	—	27,388
2009-05-05	SAVIENT PHARMACEUTICALS INCOption to Purchase Common Stock, $0.01 par valueA Award	Director	AAward	+10.5K sh	$5.37	+$56.3K	10,486
2009-05-05	SAVIENT PHARMACEUTICALS INCA Award	Director	AAward	+7,448 sh	$5.37	+$40K	23,874
2009-02-24	APPLIED NEUROSOLUTIONS INCStock OptionA Award	Director	AAward	+200K sh	—	—	199,938
2009-01-02	NORTHFIELD LABORATORIES INC /DE/A Award	Director	AAward	+13K sh	—	—	22,884
2009-01-02	NORTHFIELD LABORATORIES INC /DE/Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2008-09-10	APPLIED NEUROSOLUTIONS INCP Purchase	Director	PPurchase	+40K sh	$0.07	+$2,800	165,000
2008-09-09	APPLIED NEUROSOLUTIONS INCP Purchase	Director	PPurchase	+25K sh	$0.07	+$1,875	125,000
2008-03-07	APPLIED NEUROSOLUTIONS INCStock OptionA Award	Director	AAward	+117K sh	—	—	117,185
2007-11-16	APPLIED NEUROSOLUTIONS INCP Purchase	Director	PPurchase	+50K sh	$0.15	+$7,500	50,000
2006-06-30	SAVIENT PHARMACEUTICALS INCA Award	Director	AAward	+306 sh	$5.25	+$1,606.5	10,306
2006-06-30	SAVIENT PHARMACEUTICALS INCOption to Purchase Common Stock, $.01 par valueA Award	Director	AAward	+2,143 sh	$5.25	+$11.3K	2,143
2006-06-30	SAVIENT PHARMACEUTICALS INCA Award	Director	AAward	+306 sh	$5.25	+$1,606.5	10,306
2006-06-30	SAVIENT PHARMACEUTICALS INCOption to Purchase Common Stock, $.01 par valueA Award	Director	AAward	+2,143 sh	$5.25	+$11.3K	2,143
2005-05-18	APP Pharmaceuticals, Inc.P Purchase	President and CEO	PPurchase	+10K sh	$42.11	+$421K	60,000
2002-11-17	BAXBAXTER INTERNATIONAL INC · Employee Stock Option (Right to Buy)A Award	Senior Vice President of Issuer's Subsidiary	AAward	+84K sh	—	—	—
1999-10-28	PHARMACIA CORP /DE/(right to buy)M Exercise/Conversion	Officer	MExercise/Conversion	+5,000 sh	—	—	—
1999-10-28	PHARMACIA CORP /DE/M Exercise/Conversion	Officer	MExercise/Conversion	+5,000 sh	$10.57	+$52.9K	—

Recent filings

Accepted (ET)
Mar 194
HELLER ALAN L0001104659-21-039176
SEC(opens sec.gov)
Jun 114
HELLER ALAN L0001104659-20-072548
SEC(opens sec.gov)
Jun 174
HELLER ALAN L0001104659-19-035982
SEC(opens sec.gov)
Nov 84
HELLER ALAN L0001104659-18-066979
SEC(opens sec.gov)
Jul 34
HELLER ALAN L0001104659-18-043862
SEC(opens sec.gov)
Jul 54
Neos Therapeutics, Inc.0001104659-17-043634
SEC(opens sec.gov)
Jul 54
Neos Therapeutics, Inc.0001179110-16-027312
SEC(opens sec.gov)
May 194
Neos Therapeutics, Inc.0001179110-16-025081
SEC(opens sec.gov)
Jul 284
Neos Therapeutics, Inc.0001104659-15-053968
SEC(opens sec.gov)

Companies

Address

50 LAKEVIEW PKWY SUITE 111

VERNON HILLS, IL, 60061